版本:
中国

BRIEF-Replicel says rct-01 tendon repair clinical trial shows signs of healing chronic tendon problems

March 28 Replicel Life Sciences Inc:

* Replicel's successful rct-01 tendon repair clinical trial shows signs of healing chronic tendon problems

* Replicel Life Sciences-first-in-human clinical study meets primary endpoint demonstrating product safety, clinical potential for tendon regeneration, healing

* Replicel Life Sciences Inc - clinical trial met its goal of establishing a complete safety profile at 6 months

* Replicel Life Sciences Inc - clinical trial showed no serious adverse events related to study treatment or injection procedure Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐